Cargando…
Intrapulmonary Autoantibodies to HSP72 Are Associated with Improved Outcomes in IPF
RATIONALE: Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic interstitial lung disease, with high mortality. Currently, the aetiology and the pathology of IPF are poorly understood, with both innate and adaptive responses previously being implicated in the disease pathogenesis. Heat shoc...
Autores principales: | Mills, Ross, Mathur, Abhinav, Nicol, Lisa M., Walker, Jeremy J., Przybylski, Alexander A., Mackinnon, Alison C., Howie, Sarah E. M., Wallace, William A. H., Dransfield, Ian, Hirani, Nik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487088/ https://www.ncbi.nlm.nih.gov/pubmed/31098385 http://dx.doi.org/10.1155/2019/1845128 |
Ejemplares similares
-
Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations
por: Kulkarni, Tejaswini, et al.
Publicado: (2021) -
HSP90 Inhibition and Modulation of the Proteome: Therapeutical Implications for Idiopathic Pulmonary Fibrosis (IPF)
por: Colunga Biancatelli, Ruben Manuel Luciano, et al.
Publicado: (2020) -
Intrapulmonary Shrapnel
Publicado: (1916) -
HSP72 Up-regulation with heat acclimation
por: Schneider, Suzanne M., et al.
Publicado: (2016) -
Moving senolytics closer to the clinic in IPF
por: Kramer, Daniel, et al.
Publicado: (2023)